Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Oman Healthcare News.
Press releases published on July 29, 2025
Iridex to Report Second Quarter 2025 Financial Results on August 12, 2025
MOUNTAIN VIEW, Calif., July 29, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glaucoma and retinal …
Myriad Genetics to Release Second Quarter 2025 Financial Results on August 5, 2025
SALT LAKE CITY, July 29, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, will hold its second quarter 2025 earnings conference call at 4:30pm ET on Tuesday, Aug. 5, 2025. The …
LifeMD to Report Second Quarter 2025 Financial Results on August 5
NEW YORK, July 29, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announces that it will report financial results for the three and six months ended June 30, 2025 after the close of the U.S. …
Delaware Superior Court Jury Issues Unanimous Verdict that CG Oncology Owes No Future Royalties or Other Payments to ANI Pharmaceuticals
IRVINE, Calif., July 29, 2025 (GLOBE NEWSWIRE) -- CG Oncology, Inc. (NASDAQ: CGON), a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients with bladder cancer, …
Cardiff Oncology Reports Second Quarter 2025 Results and Provides Business Update
- Appointed Dr. Roger Sidhu as Chief Medical Officer - - Completed enrollment in randomized Phase 2 CRDF-004 trial evaluating onvansertib + standard of care for the treatment of first-line RAS-mutated metastatic colorectal cancer (“mCRC”) - - Announced …
Beta Bionics Reports Second Quarter 2025 Financial Results and Raises Full Year 2025 Guidance
IRVINE, Calif., July 29, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial results for the quarter ended June 30, 2025 and raised its …
Larimar Therapeutics Announces Proposed Underwritten Public Offering
BALA CYNWYD, Pa., July 29, 2025 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today announced that it has commenced an …
Aclaris Therapeutics Announces Positive Top-Line Results from Open-Label Phase 2a Trial of ATI-2138, a Potent and Selective Investigational Inhibitor of ITK and JAK3; Trial Achieves Primary and Key Secondary Endpoints
- Primary Endpoint Analysis Confirms Favorable Tolerability Profile of ATI-2138 Without Certain Risks Associated with Other Agents in the Class - - Efficacy Results Show Comparable Outcomes to Approved Therapies with Potential for Improved Tolerability, …
Inventiva Reports Preliminary 2025 First-Half Financial Information¹
Cash and cash equivalents at €122.1 million and €24.6 million in short-term deposits2 as of June 30, 2025 Revenues of €4.5 million recorded in H1 2025 Daix (France), New York City (New York, United States), July 29, 2025 – Inventiva (Euronext Paris and …
Inventiva publie ses informations financières préliminaires du premier semestre 2025¹
Trésorerie et équivalents de trésorerie de 122,1 millions d’euros et 24,6 millions d’euros de dépôts à court terme2 au 30 juin 2025 Chiffre d’affaires de 4,5 millions d’euros au premier semestre 2025 Daix (France), New York City (New York, Etats-Unis), le …
Grupo Bimbo Commits to Removing All Artificial Colorants by End of 2026
MEXICO CITY, July 29, 2025 (GLOBE NEWSWIRE) -- Grupo Bimbo, S.A.B. de C.V. (“Grupo Bimbo” or the “Company”) (BMV: BIMBO) is proud to announce its firm commitment to eliminate all artificial colorants from its entire product portfolio by the end of 2026. …
Hematologist Dissatisfaction with Current Warm Autoimmune Hemolytic Anemia (w-AIHA) Treatment Spurs Interest in Late-Stage Pipeline, According to Spherix Global Insights
EXTON, PA, July 29, 2025 (GLOBE NEWSWIRE) -- According to new findings from Spherix Global Insights’ syndicated Market Dynamix™ service, hematologists managing patients with warm autoimmune hemolytic anemia (w-AIHA) continue to face clinical complexity, a …
Belly Fat Burner: Why Men and Women are Using Strong Over the Counter Diet Supplements like PhenQ to Lose Stubborn Abdominal Fat
New York City, NY, July 29, 2025 (GLOBE NEWSWIRE) -- In 2025, PhenQ is setting a new standard for belly fat burners with its research-driven, natural solution, providing powerful, long-lasting support for a slimmer, healthier stomach without injections or …
Colonoscopes: Global Markets Surge as Colorectal Cancer Screening Takes Center Stage
Boston, July 29, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, “Colonoscopes: Global Markets” is projected to reach $3.4 billion by the end of 2030, growing at a CAGR of 5.4% during the forecast period from 2025 to 2030. This …
LifeLabs Deepens Support to Communities Impacted by Saskatchewan Wildfires with an Additional $5,000 Donation
Toronto, ON, July 29, 2025 (GLOBE NEWSWIRE) -- As wildfires continue to impact communities across Saskatchewan, LifeLabs is pleased to deepen its commitment to relief efforts, contributing an additional $5,000. This latest contribution brings the company’s …
Adrenocortical Carcinoma Market Forecast upto 2034—Insights into Emerging Therapies and Market Trends | DelveInsight
New York, USA, July 29, 2025 (GLOBE NEWSWIRE) -- Adrenocortical Carcinoma Market Forecast upto 2034—Insights into Emerging Therapies and Market Trends | DelveInsight The adrenocortical carcinoma market in the 7MM is anticipated to boost during the …
Hapbee Launches Integrated Affiliate and Ambassador Program to Accelerate Growth and Community Expansion
VANCOUVER, British Columbia, July 29, 2025 (GLOBE NEWSWIRE) -- Hapbee Technologies, Inc. (TSXV: HAPB) (OTC: HAPBF), the digital wellness company helping users feel better without ingesting substances, proudly announces the official launch of its technology …
RECORDATI: STRONG MOMENTUM OF THE GROUP CONTINUES IN THE FIRST HALF OF 2025 REVENUE +11.7%, EBITDA(1) +9.6%, ADJUSTED NET INCOME(2) +8.9%
Consolidated net revenue of € 1,323.8 million in the first half of 2025, +11.7% or +7.8% on a like-for-like basis(3) and at constant exchange rates (CER) EBITDA(1) of € 496.3 million, +9.6%, margin on revenue of 37.5% Adjusted net income(2) of € …
IHA’s Symphony Goes Live as Provider Directory Data Source for Covered California
OAKLAND, Calif., July 29, 2025 (GLOBE NEWSWIRE) -- The Integrated Healthcare Association (IHA) announced that its Symphony Provider Directory is now powering Covered California’s online provider directory, helping to ensure that information on providers is …
CorTec Announces Neurotech Milestone: First Human Implantation of a Brain-Computer Interface made in Germany
FREIBURG, Germany, July 29, 2025 (GLOBE NEWSWIRE) -- CorTec GmbH, a pioneer in active implantable medical technologies, today announced the first human implantation of its proprietary BCI system, Brain Interchange™, marking a pivotal advance in translating …